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Neuronal enhancers are hotspots for DNA 
single-strand break repair
 
Wei Wu1,12, Sarah E. Hill2,12, William J. Nathan1,3,12, Jacob Paiano1, Elsa Callen1, 
Dongpeng Wang1, Kenta Shinoda1, Niek van Wietmarschen1, Jennifer M. Colón-Mercado2, 
Dali Zong1, Raffaella De Pace4, Han-Yu Shih5, Steve Coon4, Maia Parsadanian2, 
Raphael Pavani1, Hana Hanzlikova6,7, Solji Park8,9, Seol Kyoung Jung8,9, Peter J. McHugh3, 
Andres Canela10, Chongyi Chen11, Rafael Casellas8,9, Keith W. Caldecott6,7 ✉, 
Michael E. Ward2 ✉ & André Nussenzweig1 ✉
Defects in DNA repair frequently lead to neurodevelopmental and neurodegenerative 
diseases, underscoring the particular importance of DNA repair in long-lived 
post-mitotic neurons1,2. The cellular genome is subjected to a constant barrage of 
endogenous DNA damage, but surprisingly little is known about the identity of the 
lesion(s) that accumulate in neurons and whether they accrue throughout the 
genome or at specific loci. Here we show that post-mitotic neurons accumulate 
unexpectedly high levels of DNA single-strand breaks (SSBs) at specific sites within 
the genome. Genome-wide mapping reveals that SSBs are located within enhancers at 
or near CpG dinucleotides and sites of DNA demethylation. These SSBs are repaired by 
PARP1 and XRCC1-dependent mechanisms. Notably, deficiencies in XRCC1-dependent 
short-patch repair increase DNA repair synthesis at neuronal enhancers, whereas 
defects in long-patch repair reduce synthesis. The high levels of SSB repair in neuronal 
enhancers are therefore likely to be sustained by both short-patch and long-patch 
processes. These data provide the first evidence of site- and cell type-specific SSB 
repair, revealing unexpected levels of localized and continuous DNA breakage in 
neurons. In addition, they suggest an explanation for the neurodegenerative 
phenotypes that occur in patients with defective SSB repair.
Recurrant sites of DNA repair in neurons
An obligatory and characteristic step of DNA repair is gap filling, in 
which excised or missing nucleotides are replaced using the undam-
aged strand as a template3. If a sufficient number of nucleotides are 
incorporated, DNA repair synthesis can be used as a proxy of the extent 
and location of endogenous DNA damage4. In light of this, we devel-
oped a method to map sites of DNA repair synthesis by sequencing 
(synthesis-associated with repair sequencing; SAR-seq). We labeled 
post-mitotic iPSC-derived glutamatergic neurons (i3Neurons5,6) on day 
6 post-differentiation with EdU for 18 hours, biotinylated the labeled 
DNA, reduced it to 150-200 bp by sonication, and then isolated the 
biotinylated DNA for high-throughput sequencing (Extended Data 
Fig. 1a). We identified >55,000 SAR-seq peaks at recurrent genomic 
locations in neurons, which were highly reproducible between different 
experiments (Fig. 1a, Extended Data Fig. 1b-d). Peaks were not caused 
by DNA synthesis during S phase7,8 because i3Neurons are post-mitotic 
(Extended Data Fig. 1e) and the SAR-seq peaks were unaffected by inhi-
bition of the replicative DNA polymerase α (Extended Data Fig. 2a-c). 
In contrast and as expected, neuronal SAR was largely prevented by 
hydroxyurea (HU), which reduces the availability of deoxyribonucleo-
tides (Extended Data Fig. 2 a, b).
The SAR-seq peaks were ~200-2,000 bp in width (averaging 901 bp) 
(Extended Data Fig. 2d), with each peak presumably comprising mul-
tiple clustered sites of DNA repair (see below). The most prominent 
neuronal SAR-seq peaks were detectable by pulse labeling with EdU 
for just 1 hour, and EdU incorporation approached saturation after 
labeling for 18 hours (Extended Data Fig. 2e, f).
When iPSCs were differentiated into skeletal muscle cells, we did 
not detect incorporation of EdU despite labeling cells for 18 hours 
(Extended Data Fig. 3a). Similarly, we failed to detect EdU incorpora-
tion in G0-arrested pre-B cells, although we could detect EdU incor-
poration in pre-B cells after inducing site-specific DNA double strand 
breaks (DSBs) (Extended Data Fig. 3b). To rule out the possibility that 
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the SAR-seq peaks were an artifact of iPSC differentiation, we labelled 
bona fide rat neurons with EdU. Similar to i3Neurons, we detected robust 
peaks of EdU incorporation at 22,196 specific sites in rat neurons 
(Fig. 1b, Extended Data Fig. 5e). Thus, the high frequency of recurrent 
DNA synthesis appears to be a specific feature of post-mitotic neurons.
DNA repair sites enriched at enhancers
Neuronal SAR-seq peaks were enriched in intragenic regions (Extended 
Data Fig. 3c, d) and further within expressed genes (Extended Data 
Fig. 3d, e). However, SAR signal intensity did not correlate with 
transcript levels (Extended Data Fig. 3e). Moreover, the sites of EdU 
incorporation were not associated with strand-specificity, as EdU 
was incorporated uniformly in both transcribed and non-transcribed 
strands (Extended Data Fig. 3f).
We next searched for specific DNA motifs among the strongest 5,000 
SAR-seq peaks. More than 25% of the sites harbored a motif similar to 
the ONECUT family of transcription factors, which was centered at 
SAR-seq peak summits (Extended Data Fig. 4a). Since ONECUT1 can pro-
mote genomic accessibility in neurons9, we compared SAR-seq peaks 
with accessible regions using ATAC-seq. 54% of all SAR-seq regions 
coincided with ATAC-seq peaks (Fig. 1a, Extended Data Fig. 4b, c), and 
the widths of SAR-seq and ATAC-seq peaks were correlated (Extended 
Data Fig. 4d), suggesting that open chromatin structure influences the 
extent of DNA synthesis.
Despite their localization in open chromatin, SAR-seq peaks were not 
enriched at promoters (Extended Data Fig. 4e-g), which exhibited only 
modest levels of DNA synthesis. However, we detected a strong correla-
tion between locations of DNA synthesis and of neuronal enhancers, 
as measured by ChIP-seq for H3K4me1, H3K27ac and MLL4 (Fig. 1a, 
Extended Data Fig. 5a, b). Nevertheless, SAR-seq peaks were not strongly 
correlated with other, non-enhancer-specific epigenetic indicators of 
open chromatin or condensed chromatin (Extended Data Fig. 5a, c). 
Similar to i3Neurons, SAR-seq peaks in primary rat neurons overlapped 
and correlated with rat H3K4me1 ChIP-seq (Extended Data Fig. 5 d-f).
We performed ultra-deep Hi-C in i3Neurons to examine chromo-
somal interactions associated with SAR-seq peaks within the context 
of topological associated domains (TADs) (Extended Data Fig. 6a). 
Enhancers with SAR-seq peaks had more intra-TAD interactions than 
enhancers without SAR-seq peaks. Consistently, H3K27ac-a mark 
of active enhancers-was significantly enriched at enhancers with 
SAR-seq peaks (Extended Data Fig. 6a). Chromatin looping interac-
tions detected by promoter capture Hi-C (pcHi-C) enables the link-
age of distal enhancer elements to their target genes10. Compared to 
random sites, we observed an 8-fold enrichment of SAR sites among 
in vivo validated enhancer elements11 that overlapped with neuronal 
H3K4me1 histone marks and a 4-fold enrichment using a pcHi-C dataset 
generated in i3Neurons (Extended Data Fig 6b)10. The latter includes 
enhancers whose activity was validated in human neurons using CRISPR 
techniques (Extended Data Fig 6c, d). Thus, distal-acting regulatory 
enhancers are hotspots of neuronal SAR.
To determine whether the enhancers with SAR-seq peaks are specific 
to neurons, we compared sites of H3K4me1 in i3Neurons and iPSCs. Only 
2% of the SAR-seq peaks overlapped with iPSC-specific H3K4me1 peaks, 
while most of the SAR-seq peaks overlapped with either neuron-specific 
or shared H3K4me1 sites (Extended Data Fig. 6e). Thus, SAR is associ-
ated with enhancers that are active in differentiated neurons.
Gene Ontology (GO) analysis of the genes containing SAR-seq peaks 
revealed than an enrichment of GO terms related to nervous system 
function (Extended Data Fig. 6f). We then further characterized the 
neuronal enhancers that were associated with SAR. Super-enhancers 
(SE) are a large collection of enhancers that drive transcription of genes 
involved in cell identity. Using H3K27ac ChIP-seq, we found approxi-
mately 1,300 SE in i3Neurons. Interestingly, 90% of SE exhibited SAR-seq 
peaks, whereas less than 25% of conventional enhancers possessed 
SAR-seq peaks (Extended Data Fig. 6g, h). Collectively, these data iden-
tify enhancers and genes associated with neuronal function as hotspots 
of recurrent DNA synthesis.
PARP activity at neuronal enhancers
Given the close association between unrepaired DNA strand breaks 
and neurodegeneration1,2, we wondered if the sites of EdU incorpora-
tion might reflect sites of DNA break repair. To test this, we measured 
the activity of poly(ADP-ribose) polymerases (PARPs) at the sites of 
DNA synthesis. Various types of DNA damage including SSBs, DSBs, 
and single-strand gaps activate PARP1 and PARP212,13. PARP activity 
signals the presence of these lesions by modifying localized proteins 
with poly(ADP-ribose) (PAR)12,13. When we monitored ADP-ribosylation 
in individual neurons14, we detected focal sites of nuclear ADP-ribose. 
These focal sites, along with pan-nuclear staining, increased following 
treatment with the genotoxin methylmethansulfate (MMS) (Fig. 1c, 
Extended Data Fig. 7a). To determine whether the sites of endogenous 
ADP-ribosylation were localized to sites of neuronal DNA synthesis, 
we employed ADP-ribose ChIP-seq. As a positive control, we first con-
firmed could detect ADP-ribosylation occurring at site-specific DSBs 
(Extended Data Fig. 7b). In i3Neurons, we found that the endogenous 
sites of ADP-ribosylation co-localized with SAR-seq peaks (Fig. 1d, 
Extended Data Fig. 7c), suggesting that the recurrent sites of DNA 
synthesis are associated with DNA strand break repair.
DNA repair is not associated with DSBs
Neuronal activity has been reported to cause DSBs generated by topoi-
somerase 2 (TOP2)15,16. TOP2-induced DSBs can promote the expres-
sion of early response genes15, associating these DNA breaks with 
regions of transcriptional activity17,18. Treatment of i3Neurons with 
etoposide to trigger TOP2-induced DSBs resulted in DNA synthesis 
within gene bodies (Extended Data Fig. 8a, b). However, most of the 
sites of etoposide-induced DNA synthesis were distinct from those 
detected in untreated neurons (Extended Data Fig. 8a, b). In addition, 
we did not detect DSBs in unchallenged i3Neurons as measured by either 
γ-H2AX/53BP1 immunostaining (Extended Data Fig. 8c) or by END-seq 
(Extended Data Fig. 8d)19. Thus, sites of DNA synthesis in neuronal 
enhancers are independent of DSBs.
SSBs at sites of DNA synthesis
In addition to DSBs, PARP1 and/or PARP2 are also activated at SSBs and 
subsequently recruit the XRCC1 protein complex that accelerates SSB 
repair20,21. We therefore examined the genomic localization of XRCC1 
by ChIP-seq. Similar to sites of PARP activity, XRCC1 co-localized with 
SAR-peaks, and the intensity of XRCC1 binding correlated with the 
intensity of EdU incorporation in both human i3Neurons and rat pri-
mary neurons (Fig. 1d, Extended Data Fig. 7c and Extended Data 8e-g). 
Thus, sites of DNA synthesis colocalize with sites of PARP activation 
and XRCC1-associated SSB repair.
To directly map SSBs at nucleotide resolution, we treated agarose- 
embedded i3Neuron plugs with recombinant single strand-specific S1 
nuclease in situ to convert SSBs into DSBs, which we then detected using 
END-seq. To test whether this method would successfully convert DNA 
nicks into DSBs, we first incubated the i3Neuron agarose plugs with the 
site-specific nicking endonuclease Nt.BspQI prior to S1 nuclease treat-
ment. Nt.BspQI nicks were readily converted into DSBs by S1 (Extended 
Data Fig. 9a). Moreover, S1-END-seq could detect nicks generated by an 
inducible CAS9 nickase expressed in G1-arrested MCF10 cells (Extended 
Data Fig. 9b,c). However, S1-END-seq alone failed to detect endogenous 
SSBs in i3Neurons (Fig 2a, Extended Data Fig. 9a).
We surmised that failure to detect endogenous SSBs in neurons 
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incubated i3Neurons with a mixture of chain terminating dideoxynucle-
osides (ddA+ddC+ddT+ddG, denoted ddN). Strikingly, this led to robust 
SSB accumulation as detected by S1-END-seq (Fig. 2a), which colocal-
ized extensively with SAR-seq peaks (Fig. 2a, b, and Extended Data 
Fig. 9d, e). Many of the SAR-seq peaks contained multiple S1-END-seq 
peaks (Fig. 2a, inset). Each peak spanned an average of ~25 nucleo-
tides (Extended Data Fig. 9f), thus comprising multiple-clustered 
single-strand gaps. Interestingly, we also detected a very low-level of 
DSBs at SAR-seq peaks following chain termination, which were inde-
pendent of S1 nuclease treatment and likely reflected closely apposed 
SSBs on opposite DNA strands (Fig. 2b).
S1-END-seq enabled the identification of the location of the endog-
enous SSBs with much higher resolution than did SAR-seq, which is lim-
ited to the size of the sonicated fragments (150-200 nt). The improved 
resolution revealed a prevalence of C/G nucleotides at S1-END-seq 
peak summits on positive or negative strands (Fig 2c), and that CpG 
dinucleotides were highly enriched at SAR sites (Extended Data Fig. 9g, 
h). Collectively, these data provide direct evidence for the site-specific 
formation of clustered SSBs in neuronal enhancers at or near C/G 
nucleotides.
SAR involves long-patch SSB repair
SSB repair comprises both short-patch and long-patch sub pathways, 
in which single or multiple nucleotides are replaced at the site of 
the SSB, respectively22,23. PARP1 and XRCC1 promote the repair of a 
wide spectrum of SSBs, primarily by short-patch repair. We therefore 
examined the impact of inhibiting and/or depleting these proteins on 
neuronal DNA synthesis. We observed a reproducible increase in EdU 
incorporation at SAR sites if neurons were co-incubated with any of 
three independent inhibitors of PARP1, or if PARP1 was depleted using 
CRISPR interference (CRISPRi)24 (Fig. 3a and Extended Data Fig. 10a,b). 
Depletion of XRCC1 similarly led to a prominent increase in EdU incor-
poration at sites of SAR (Fig. 3b and Extended Data Fig. 10c- e). These 
data suggest that if PARP1/XRCC1-dependent short-patch SSB repair 
is impeded, compensatory long-patch SSB repair is increased.
During short-patch SSB repair, a single nucleotide is replaced at 
the site of the break22,23,25. Nucleotide replacement typically requires 
DNA polymerase β (POLβ), which interacts directly with XRCC120. In 
contrast, during long-patch repair, alternative DNA polymerases such 
as POLε and POLδ can generate a 2-20 nucleotide DNA repair patch. 
Consistent with this, we found that depletion of POLβ resulted in a 
dramatic increase in DNA synthesis at neuronal enhancers (Fig. 3c; 
Extended Data Fig. 10f-h). In contrast, incubation with aphidicolin 
(Aph), an inhibitor of POLε and POLδ, greatly reduced SAR in both 
wild-type and POLβ-depleted neurons when used at concentrations 
(50μM) that inhibit cellular repair synthesis4,26 (Fig. 3c; Extended Data 
Fig. 10i). Collectively, these data indicate that neuronal site-specific 
SSBs are repaired by both short-patch and long-patch repair, with the 
latter pathway being the primary source of SAR-seq signal.
SSBs and active cytosine demethylation
The detection of DNA repair synthesis at neuronal enhancers could 
indicate that the latter are sites of increased DNA damage or, alterna-
tively, that they are sites of preferential DNA repair. Our observations 
using S1-END-seq, in which we see that SSBs are enriched at neuronal 
enhancers, strongly supports the first hypothesis. To test this fur-
ther, we treated i3Neurons with MMS to introduce SSBs stochasti-
cally across the genome. We predicted that if DNA repair is targeted to 
enhancer sites, induction of random SSBs across the genome should 
not affect the location of the SAR-seq peaks. However, despite the 
expected increase in the overall level of EdU incorporation 2-5 fold, 
MMS ablated the appearance of SAR-seq peaks at enhancers. This 
observation suggests that elevated levels of SSBs occur specifically at 
neuronal enhancers and account for the peaks of DNA repair synthesis 
at these sites, rather than a selective and site-specific repair process 
(Extended Data Fig. 11a).
What is the source of the localized SSBs? Oxidative DNA lesions such 
as 8-oxoguanine are strongly implicated sources of DNA damage in 
the brain, but unlike the sites of DNA repair synthesis detected here 
such lesions have not been shown to preferentially accumulate in open 
chromatin or at enhancers27. In contrast, enhancers may be especially 
vulnerable to SSBs induced by TOP1, a topoisomerase enzyme that is 
implicated in enhancer activation28,29. However, such SSBs are also 
unlikely to be the source of the localized SSBs, since depletion of the 
polynucleotide kinase 3’-phosphatase (PNKP)-which is recruited by 
XRCC1 to repair TOP1-induced SSBs30,31- had only a small impact on the 
SAR-seq peaks (Extended Data Fig. 11 b, c). This was in contrast to the 
DNA repair synthesis of bona fide TOP1-induced SSBs that we triggered 
by treating neurons with the TOP1 poison camptothecin, which were 
increased by PNKP depletion and located in gene bodies rather than 
in enhancers (Extended Data Fig. 11d).
Given our finding that SSBs associated with SAR-seq peaks were 
enriched at C/G nucleotides (Fig. 2c and Extended Data Fig. 9g, h), 
we entertained the possibility that these SSBs were sites of cytosine 
demethylation (Fig. 4c). Consistent with this idea, active DNA demeth-
ylation of cytosine at CpG sites occurs preferentially at enhancers32, is 
10-fold more active in post-mitotic neurons than peripheral cell types33, 
and generates SSBs that are intermediates of XRCC1-associated, but 
not PNKP-associated, BER32,34. Active demethylation via ten-eleven 
translocation (TET) family (TET1, TET2, and TET3) enzymes is initi-
ated through progressive oxidation of 5mC to 5hmC, 5fC, or 5caC, and 
steady state levels of 5hmC account for approximately 40% of modified 
cytosines in the brain33. Using labeling methods to detect 5hmC and 
5fC35,36, we mapped oxidized forms of 5-methylcytosine genome-wide in 
i3Neurons. We found that the sites of both DNA repair synthesis (meas-
ured by SAR-seq) and SSBs (measured by S1-END-seq) overlapped with 
peaks of 5hmC and 5fC, and the intensity of SSBs correlated with that 
of 5hmC and 5fC (Fig. 4a, b and Extended Data Fig. 11e, f). While future 
studies will be needed to determine the precise source(s) of SSBs at 
neuronal enhancers, our data implicate cycles of cytosine methyla-
tion and demethylation at neuronal enhancers as a potential source 
of neuronal site-specific DNA single-strand breakage.
Conclusions
Our study reveals that human post-mitotic neurons are subject to an 
unexpected level of localized DNA synthesis that is associated with 
ongoing sites of SSB repair at neuronal enhancers. The scaffold protein 
XRCC1 is of particular importance during SSB repair because it is physi-
cally associated with a variety of SSB repair enzymes including TDP1, 
POLβ, PNKP, APTX, and DNA ligase III (LIG3)20, some of which if mutated 
result in hereditary neurodegenerative diseases1,2. Failure to repair the 
site-specific SSBs that we have discovered here may thus contribute 
to such diseases, though we do not rule out an involvement of other 
SSB sources. Unrepaired SSBs may trigger neuropathology in several 
ways, such as via excessive or aberrant activation of PARP137. In addition, 
our current data raise the possibility that an increased dependency 
on DNA repair synthesis at specific sites of the genome increases the 
mutational burden in long-lived neurons38. For example, it is possible 
that an accrual of mutations at sites of recurrent DNA repair synthesis 
within enhancers could lead to aberrant gene expression, resulting in 
neurological dysfunction over time.
In summary, we describe new methods that enable genome-wide 
mapping of endogenous sites of frequent DNA single-strand breakage 
and repair synthesis in post-mitotic neurons. Our findings identify 
enhancers as hotspots of DNA damage in human post-mitotic neurons, 
perhaps explaining why DNA SSB repair is important for neurological 



























Note: During the preparation of this manuscript, we became aware of 
the closely related work of D. Reid et al., which demonstrated recurrent 
DNA repair sites in embryonic stem cell-derived neurons39.
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Fig. 1 | SAR-seq peaks occur within enhancers and are associated with PARP 
activation. a) Genome browser screenshots of SAR-seq (n=3), ATAC-seq (n=1), 
H3K4me1 (n=2), H3K27ac (n=1), and MLL4 (n=1) ChIP-seqs in i3Neurons. Inset, 
zoomed-in screenshot of the indicated region highlighting overlapping peaks. 
b) Genome browser screenshot of SAR-seq performed in rat primary neurons 
(n=1) as well as input. The culture was co-incubated with 5μM aphidicolin to 
block DNA replication of S phase glial cells. c) Representative images of 
anti-poly(ADP-ribose) immunofluorescence staining (PAR, green) and 
neuronal marker Tubulin Beta 3 (red) in i3Neurons counterstained with DAPI 
(blue) (data are representative of three independent experiments). As a 
positive control, cells were treated with 0.1 mg/ml MMS for 15 min. Boxed 
regions in top panels are enlarged in bottom panels. d) Heatmaps of SAR-seq, 
XRCC1 and PAR ChIP-seq signal ±1kb surrounding SAR-seq peak summits in 
i3Neurons, ordered by SAR-seq intensity.



























Fig. 2 | Single-strand breaks detected by S1-END-seq following ddN 
incubation. a) Genome browser screenshots illustrating the overlap in 
i3Neurons between sites of SAR-seq and SSBs (S1-END-seq) detected in the 
presence of ddN (n=1) to block DNA ligation, or in its absence (“NT”, n=1). 
S1-END-seq signal was separated by positive (black) and negative (grey) 
strands. Inset, zoomed screenshots demonstrating the presence of multiple 
SSBs within one SAR-seq peak. b) Aggregate plots of S1-END-seq (red: 
positive-strand, blue: negative-strand) and END-seq in the presence of ddN 
(n=1) (black: positive-strand, grey: negative-strand) signal ±500 bp around 
SAR-seq peak summits. c) Composite DNA sequence motif within ±5 bp 
surrounding the SSB summits on the positive strand (right panel) and on the 
negative strand (left panel) of the 10,000 most prominent S1-END-seq peaks.




























Fig. 3 | Localized SSB repair in neurons is comprised of short-patch and 
long-patch sub-pathways. a) Heatmaps of SAR-seq intensities ±1 kb 
surrounding SAR-seq peak summits for i3Neurons treated with the indicated 
PARP inhibitors (n=3) or expressing non-targeted control (sgControl, n=1) or 
PARP1-targeted (sgPARP1, n=2) CRISPRi. Aggregate plots of SAR-seq intensity 
are shown in the top panel. NT: non-treated; rep: replicate. RPM: reads per 
million. b) Heatmaps of SAR-seq intensities ±1 kb surrounding SAR-seq peak 
summits for i3Neurons expressing non-targeted control (sgControl, n=2) or 
XRCC1-targeted (sgXRCC1, n=2) CRISPRi. c) Heatmaps of SAR-seq intensities 
±1kb surrounding SAR-seq peak summits for i3Neurons expressing 
non-targeted (sgControl, n=2) or POLB-targeted (sgPOLB, n=2) CRISPRi. Where 
indicated, neurons were treated with 50 μM Aphidicolin (Aph) for 24 hours 
prior to and during EdU incorporation.



























Fig. 4 | Localized SSB repair in neurons correlates with sites of oxidized 
5-methylcytosine. a) Genome browser screenshot illustrating the overlap in 
i3Neurons between sites of 5hmC (5hmC-SEAL, n=2), 5fC (5fC-SEAL, n=2), SSBs 
(ddN S1-END-seq), DNA repair synthesis (SAR-seq), and H3K4me1 ChIP-seq. 
Both positive (black) and negative (grey) S1-END-seq signal are shown.  
b) Heatmaps of signals for DNA repair synthesis (SAR-seq), SSBs (ddN 
S1-END-seq), 5fC (5fC-SEAL), and 5hmC (5hmC-SEAL) in i3Neurons, plotted ±1 kb 
surrounding the summits of the SAR-seq peaks and ordered by SAR-seq 
intensity. c) Model depicting the balance between short-patch and long-patch 
SSB repair at neuronal enhancers. Note that while our data implicate SSBs 
arising during the base excision repair of modified cytosine residues within 
enhancers, we do not exclude the occurrence of other sites and sources of SSBs.






























All induced pluripotent stem cell (iPSC) experiments used the WTC11 
line, which was derived from a healthy human male participant and 
obtained from the Coriell cell repository. All policies of the NIH Intra-
mural Research Program for the registration and use of this iPSC line 
were followed. The WTC11 iPSC line was validated to have a normal 
male karyotype, as expected, and was confirmed to be mycoplasma 
free based on the Lonza "MycoAlert" mycoplasma testing kit. iPSC 
culture was performed as described previously5. Tissue culture treated 
dishes were coated with hESC-qualified matrigel (Corning, REF 354277). 
Matrigel was removed and iPSCs were plated in Essential 8 Medium (E8; 
Thermo Fisher Scientific, Cat. No. A1517001) and 10 μM ROCK inhibitor 
(RI; Y-27632; Selleckchem, Cat. No. S1049). iPSCs were maintained in 
a 37°C, 5% CO2 incubator and fed every 1-2 days as needed. Cells were 
split using either accutase (Life Technologies, Cat. No. A1110501) for 
enzymatic dissociation into single cells or EDTA (0.5mM; Life Tech-
nologies, Cat. No. 15575020) for routine passaging. Media was sup-
plemented with 10 μM RI to promote survival during passaging. As 
necessary iPSCs were frozen in 90% ES-qualified fetal bovine serum 
(FBS) (Sigma Aldrich, Cat. No. ES-009-B) and 10% DMSO (Mediatech 
Inc., Cat. No. 25-950-CQC), and then thawed rapidly at 37°C, followed 
by removal of FBS/DMSO and plating in E8+RI medium.
i3Neuron culture
The human iPSCs used in this study were previously engineered5,6 to 
express mouse Neurogenin-2 (NGN2) under a doxycycline-inducible 
promoter integrated at the AAVS1 safe harbor in the WTC11 background, 
+/- CAG-dCas9-BFP-KRAB at the CLYBL promoter24. For neuronal differ-
entiation, 20-25 million iPSCs were plated on day 0 onto a 15 cm plate in 
N2 media composed of knockout DMEM/F12 media (Life Technologies 
Corporation, Cat. No. 12660012) with N2 supplement (Life Technologies 
Corporation, Cat. No. 17502048), 1x GlutaMAX (Thermofisher Scien-
tific, Cat. No. 35050061), 1x MEM nonessential amino acids (NEAA) 
(Thermofisher Scientific, Cat. No. 11140050), 10 μM ROCK inhibitor 
(Y-27632; Selleckchem, Cat. No. S1049), and 2 μg/mL doxycycline (Clon-
tech, Cat. No. 631311). N2 media was changed once a day for two more 
days. Day 3 cells were replated onto freshly-prepared poly-L-ornithine- 
(PLO; 0.1 mg/ml; Sigma, Cat. No. P3655-10MG) coated dishes as follows: 
Cells were washed with PBS, dissociated with accutase for 10 minutes at 
37°C, washed and plated in i3Neuron Culture Media: BrainPhys media 
(STEMCELL Technologies, Cat. No. 05790) supplemented with 1x B27 
Plus Supplement (ThermoFisher Scientific, Cat. No. A3582801), 10 ng/
mL BDNF (PeproTech, Cat. No. 450-02), 10 ng/mL NT-3 (PeproTech, Cat. 
No. 450-03), 1 mg/mL mouse laminin (Sigma, Cat. No. L2020-1MG), and 
2 μg/mL doxycycline (Clontech, Cat. No. 631311). For 10 cm plates used 
in SAR-seq or CHIP-seq, 12-15 million neurons were plated. For 15 cm 
plates 30-45 million neurons were plated. For ibidi slides used in imag-
ing experiments, 0.2 million neurons per well were plated. Unless other-
wise noted, i3Neurons were fed on day 6 during a half media change and 
harvested on day 7. For i3Neurons cultured beyond 7 days, half media 
changes were conducted three times per week. In some experiments 
pre-differentiated i3Neurons were frozen on day 3 in 90% fetal bovine 
serum (Sigma Aldrich, Cat. No. ES-009-B) and 10% DMSO (Mediatech 
Inc., Cat. No. 25-950-CQC), and then thawed rapidly at 37°C, followed 
by removal of FBS/DMSO and plating in i3Neuron Culture Media. We 
did not detect any differences for experiments where day 3 neurons 
were thawed or plated immediately following differentiation.
iMuscle culture
To generate skeletal muscle myoblasts from human iPSCs, we engi-
neered a doxycycline-inducible vector harboring a MyoD1 transcription 
factor transgene immediately followed by a co-inducible short hairpin 
RNA targeting Oct4 and selection marker/fluorescent protein cassette 
(MyoD-O iPSCs), similar to previous methods40. We used the PiggyBacTM 
system to facilitate delivery and genome integration of the transgene 
cassette. To increase transposase expression in iPSCs, we subcloned 
the PiggyBacTM transposase under a long version of the eF1a promoter, 
and co-transfected this transposase vector with the MyoD1 donor vec-
tor into iPSCs using lipofectamine stem (Thermofisher Scientific, Cat. 
No. STEM00015). Transfection rates were approximately
55% based on fluorescence of a co-expressed reporter gene, and we 
were able to obtain 100% MyoD1-O iPSCs after puromycin selection of 
iPSCs harboring stable integration of the transcription factor cassette.
To induce myogenic differentiation, MyoD-O iPSCs were dissociated 
using accutase (37°C for 10 minutes) and resuspended in myogenic 
induction media (MIM) and plated with 3x106 iPSCs per 10 cm dish. 
The MyoD-O iPSCs differentiation was modified from a recent report41. 
The MIM contained DMEM/F12 HEPES (Gibco, Cat. No. 11-330-032) 
supplemented to a final concentration of 1 mM sodium pyruvate, 1x 
MEM nonessential amino acids (NEAA) (Thermofisher Scientific, Cat. 
No. 11140050), 0.1 mM 2-mercaptoethanol (Gibco, Cat. No. 21985023), 
10 μg/mL insulin (Roche, Cat. No. 11376497001), 2 μg/mL doxycycline 
and 10 μM RI.
After plating the MyoD-O iPSCs in MIM at day 0, fresh media was 
supplied daily until 80% confluency or more (day 6). Myoblast mor-
phology was observed beginning at day 2 followed by myotube-like 
morphology at day 5. On day 6, the glycogen synthase kinase 3 (GSK-3) 
inhibitor, CHIR 99021, was administered for 48 hours to enhance myo-
blast differentiation and stimulate fusion (3 μM, Tocris, Cat. No. 4423) 
as reported by others42,43. At day 9 post-doxycycline, the differentiating 
myoblasts were harvested.
Lenti-virus production for CRISPRi guide delivery
Lenti-X Human Embryonic Kidney (HEK) cells were plated onto dishes 
coated with poly-L-ornithine (0.1 mg/ml PLO) at a density of 10-15 mil-
lion cells (10 cm dish) or 30-45 million cells (15 cm dish) per dish in warm 
DMEM, high glucose GlutaMAXTM Supplement media (Life Technolo-
gies, Cat. No. 10566024) with 10% FBS (Sigma, Cat. No. TMS-013-B) 
and then cultured overnight to achieve approximately 90% conflu-
ency. The next morning cells were transfected using Lipofectamine 
3000 (Life Technologies, Cat. No. L3000150). For each transfection, 
2.4 mL of room temperature Opti-MEM media (Fisher Scientific, Cat. 
No. 31985062) and 60 μL of Lipo 3K were combined and incubated at 
room temperature for 5-20 minutes. Then in another tube, 2.4 mL of 
room temperature Opti-MEM, 80 μL of P3000, 13.3 μg of psPAX2, 4.5 
μg of pMD2G, 1.8 μg of pAdVantage, and 19.5μg of the lenti vector of 
interest were combined. The contents of the two tubes were combined 
and incubated at room temperature for 30 minutes. This mixture was 
then added dropwise to a plate of Lenti-X cells and cultured overnight. 
The next morning the media was changed with 36 mL of fresh warm 
DMEM+Glutamax+10% FBS media supplemented with 72 μL viral boost 
reagent (ALSTEM, Cat. No. VB100). Then 2-3 days later the media con-
taining virus was collected, centrifuged to remove cell debris and the 
supernatant was concentrated using Lenti-X concentrator, following 
the manufacturer’s protocol (Takara Bio, Cat. No. 631231). The viral 
pellet was gently dissolved in PBS at either 1:10 or 1:100. Concentrated 
virus was then aliquoted and stored at -80°C for future use.
CRISPRi plasmids
The sgRNAs used in this study were cloned into either the pU6-sgRNA 
EF1Alpha-puro-T2A-BFP vector (gift from Jonathan Weissman; Addgene 
#60955)24,44 or the pMK1334 CROPSeq vector (gift from Martin Kamp-
mann; Addgene #127965)24. Guides were driven under the mouse U6 pro-
moter. The sgRNA sequences were as follows: non-targeting controls: 
GTCCACCCTTATCTAGGCTA or GACCAGGATGGGCACCACCC; PARP1: 
GGGTGCGGCGTGTTCGGTGG; XRCC1: GGTAGAGTATGGGGTCCGAG. 




























Puromycin selection for CRISPRi knockdown i3Neurons
To perform CRISPRi knockdown 1-4 million iPSCs were transduced 
with an aliquot of sgRNA-expressing virus immediately following an 
accutase split prior to cell attachment. Media was changed the next 
day to remove residual virus. Two days after transduction, iPSCs were 
split into accutase and plated at low density in E8+RI media containing 
10 μg/mL puromycin. The following morning cells were washed with 
PBS and given fresh E8 or E8+RI media. Cells were then expanded for 
1-2 days before inducing differentiation into neurons. sgRNA knock-
down efficiency was tested at the iPSC stage and confirmed in day 7 
i3Neurons via QT-PCR.
Immunofluorescence and Microscopy
For imaging, i3Neurons were plated onto 96-well plates (0.05x106 cells 
per well; Perkin Elmer, Cat. No. 6055302) or on μ-Slide glass bottom 
IBIDI slides (or 0.2x106 per well; IBIDI). Prior to fixation, if indicated, 
cells were treated with 0.1 mg/ml MMS for 15 min, 10 μM PARGi for 20 
min, or 50 μM Etoposide (ETO) for 1h. Cells were then washed with 
PBS and fixed in 4% paraformaldehyde in PBS for 15 minutes at room 
temperature. Cells were then washed 3 times in PBS, permeabilized 
in 0.5% Triton X-100 for 5 minutes at room temperature and blocked 
in 1% BSA/ 0.2% Triton in PBS for 1 hour at room temperature before 
incubation with primary antibodies. Primary antibodies and dilutions 
used were as follows: anti-poly-ADP-ribose (1:500, Sigma-Aldrich 
MABE1031), anti-53BP1 (1:1000, Novus Biologicals, #NB100-305), 
anti-Phospho-Histone H2AX (1:5000, Millipore, #JBW301), and 
anti-tubulin β3 (TUBB3, 1:5000, Biolegend #801201). Immunofluo-
rescence detection was achieved using fluorochrome-conjugated sec-
ondary antibodies as follows: Rhodamine Red-X AffiniPure Donkey 
anti-Mouse IgG (1:1000, Jackson Labs #715-295-151) for detecting of 
TUBB3; Alexa Fluor 488 goat anti-rabbit (1:1000, Invitrogen #A11034) 
for detection of PAR or 53BP1; Alexa Fluor 555 goat anti-mouse (1:2000, 
Invitrogen #A21422) for detection of yH2AX. EdU was visualized using 
Click-iT™ Plus EdU Cell Proliferation Kit for Imaging, Alexa Fluor™ 488 
dye (Life Technologies, Cat. No. C10637) following the manufacturer 
instructions. Finally, DNA was counterstained with DAPI (2 μg/mL, 
Thermo Fisher Scientific #62248). Images were acquired on an inverted 
Nikon spinning-disk confocal microscope (Nikon Eclipse T1), using a 
60x 1.40 NA oil-immersion objective.
Flow Cytometry
For cell cycle profiling, cells were incubated with 10 μM 
(5-ethynyl-2’ -deoxyuridine) for 30 min at 37 °C and stained using the 
Click-IT EdU Alexa Fluor 488 or 647 Flow Cytometry Assay Kit (Ther-
moFisher) according to the manufacturer’s instructions. DNA con-
tent was measured by DAPI (4′,6-diamidino-2-phenylindole, 0.5 μg 
ml−1). Data analysis was done using FlowJo v10 software.
Rat primary neuron cell culture
All animal procedures were conducted following the NIH Guide for the 
Care and Use of Laboratory Animals, under the Animal Study Proposal 
#19-011 approved by the NICHD Animal Care and Use Committee. 10-11 
week old pregnant albino rats were delivered to our facility on day 17 
of gestation. They were housed under a 12 h light-dark cycle for 24 h 
with access to food and water ad libitum. The following day, the animals 
were sacrificed by carbon dioxide inhalation followed by decapitation 
prior to embryo extraction and preparation of neurons. Neurons from 
embryos of the same litter were pooled for each experiment.
Primary rat cortical neurons were prepared at embryonic day 18 (E18) 
as previously described45. Rats at E18 were harvested and euthanized 
by decapitation. The brain was collected and meninges were removed, 
after which cortexes were isolated in sterile Hank’s medium (Hanks' 
Balanced Salt Solution (HBSS), 20 mM HEPES, pH 7.5). Cortexes were 
then collected and treated with 0.25% trypsin (Gibco), and 100 μg/ml 
DNase (Roche) for 15 minutes at 37°C. One volume of adhesion medium 
(Dulbecco’s Modified Eagle Medium (DMEM) without phenol red, 
4.5 g/L glucose, 25 mM HEPES, 10% heat-inactivated horse serum 
(Gibco), 100 U/mL penicillin and 100 mg/mL streptomycin) was 
added to stop trypsin enzymatic action. The tissue was then disrupted 
mechanically by pipetting it through a 10 ml serological pipet. Cells 
were then strained through a 70 μm nylon filter (Corning) and centri-
fuged at 700 g for 10 minutes. The cell pellet was resuspended in 5 ml of 
adhesion medium and cells counted. 10-25 million cells were plated on 
10 cm culture dishes previously coated with poly-L-lysine (Sigma) and 
5 μg/mL laminin (Roche). After 2 hours, the neurons were adherent 
to the plate and the medium was changed to complete neurobasal 
medium (CNB) (neurobasal medium (Gibco), 1X B27 serum-free (Gibco), 
4.5 g/L glucose, and 100 U/mL, penicillin-streptomycin (Gibco)) and 
supplemented with 5μM aphidicolin (Aph) to eliminate residual divid-
ing cells. Primary neurons neurons were then cultured for 7-8 days 
before harvesting for CHiP-seq or SAR-seq.
SAR-seq
Neurons and iMuscle cells were incubated with 20 μM EdU for 18 hours, 
unless otherwise noted. Cells were harvested and fixed as follows. Cells 
were washed with PBS, incubated with accutase for 5-10 mins, collected 
with a cell scrapper, pelleted at 200 × g for 5 minutes and resuspended 
in cold 0.1% BSA in PBS. Cold methanol was then added dropwise during 
slow vortexing to 80% final concentration. Samples were kept on ice 
for 20 minutes and then stored at -20°C until processing.
Copper catalyzes azide-alkyne click chemistry. For biotin labeling 
via Click-iT reaction, cells were first washed 1x in PBS, permeabilized 
with 0.2% Triton-X100/PBS for 10 minutes on ice, and then washed 1x 
in PBS. Then the following were added in order: 3 mM copper sulfate 
(Sigma), 50 μM biotin azide (ThermoFisher, Cat. No. B10184), and 1X 
Click-iT additive (ThermoFisher, Cat. No. C10424) for 2 hours shaking at 
room temperature. Cells were then washed one time in PBS and lysed in 
50 mM Tris pH 8.0 with 1% SDS and Proteinase K overnight at 37°C. DNA was 
extracted with UltraPure Phenol:Chloroform:Isoamyl Alcohol (25:24:1, 
v/v) (Invitrogen) according to manufacturer’s instructions, followed 
by 2.5:1 volume ethanol and 1:10 volume sodium acetate precipitation. 
DNA pellets were resuspended in TE buffer and sheared to 150-200 bp 
fragments using Covaris S220 sonicator at 10% duty cycle, 175 peak 
incident power, 200 cycles per burst, for 240 seconds. DNA was again 
precipitated by 2.5:1 volume ethanol and 1:10 volume sodium acetate 
and resuspended in TE buffer. Biotin-EdU fragments were pulled down 
using MyOne Streptavidin C1 Beads (ThermoFisher, Cat. No. 650-01). 
Before pulldown, 35 μL of Dynabeads were washed two times with 1 mL 
1X Wash and Binding buffer (1X W&B) (10 mM Tris-HCl pH 8.0, 1 mM 
EDTA, 1 M NaCl, 0.1% Tween20) on a DynaMag-2 magnetic separator (Inv-
itrogen, Cat. No. 12321D) and resuspended in 2X W&B (10 mM Tris-HCl 
pH8.0, 2 mM EDTA, 2 M NaCl, 0.2% Tween20). Equal volume of Dyna-
beads in 2X W&B were added to DNA in TE and incubated at 24°C shaking 
in a ThermoMixer C at 800 rpm for 30 minutes. Dynabeads bound to 
biotin-EdU fragments were washed three times in 1 mL of 1X W&B, two 
times in 1 mL EB, and one time in 1mL 1X T4 DNA Ligase Buffer (NEB). 
Dynabeads were resuspended in 50 μL end-repair reaction mix (1X T4 
DNA Ligase Buffer, 0.4 mM of dNTPs, 2.7 U of T4 DNA polymerase (NEB), 
9 U of T4 Polynucleotide Kinase (NEB), and 1 U of Klenow fragment 
(NEB)) and incubated at 24°C shaking at 800 rpm for 30 minutes. Dyna-
beads were washed one time in 1mL 1X W&B, two times in 1mL EB, and 
one time in 1 mL NEBuffer 2 (NEB) and resuspended in 50 μL of A-tailing 
reaction mix (1X NEB dA-Tailing Buffer and 20 U Klenow fragment exo- 
(NEB)), followed by incubation at 37°C shaking at 800 rpm for 30 min-
utes. Dynabeads were then washed again 1x in 1 mL NEBuffer 2 and 
resuspended in 115 μL of ligation reaction mix (1X Quick Ligase Buffer 
(NEB), 6000 U Quick Ligase (NEB), 5 nM annealed TruSeq truncated 
adapter) and incubated at 25°C shaking at 600 rpm for 20 minutes. 




























were washed three times in 1 mL 1X W&B, three times in 1 mL EB, and 
finally resuspended in 8 μL EB + 10 μL 2X Kapa HiFI HotStart Ready Mix 
(Kapa Biosciences). 10 mM primers 5’-CAAGCAGAAGACGGCATACGA- G 
ATXXXXXXGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T-3’ and 
5’-AATGATACGGCGACCACCGAGATCTACACTCTTTCC CTACACGAC 
GCTCTTCCGATC*T-3’ (* indicates a phosphothiorate bond and a 
NNNNNN TruSeq index sequence) were added with 37 μL PCR reaction 
mix (20 μL 2X Kapa HiFI HotStart Ready Mix, 17 μL H2O) for final volume 
of 60 μL. DNA was amplified using PCR program: 98°C, 45 seconds; 15 
cycles [98°C, 15 seconds; 63°C, 30 seconds; 72°C, 30 seconds]; 72°C, 5 
minutes. PCR products were separated from DynaBeads and cleaned 
using 1.8X volume AMPure Beads XP. 150-200 bp bands were isolated on 
2% agarose gel and purified using QIA-quick Gel Extraction Kit (Qiagen). 
Prior to sequencing using Illumina NextSeq 550 (75 bp single read), 
library concentrations were calculated by KAPA Library Quantification 
Kit for Illumina Platforms (Kapa Biosystems).
To specifically sequence only EdU-incorporated strands of DNA 
(Strand-Specific SAR-seq), SAR-seq was followed exactly as above with 
additional steps prior to PCR amplification. After washing three times in 
1 mL 1X W&B and three times in 1 mL EB post-ligation, Dynabeads were 
washed in 50 μL 1X SSC buffer and resuspended in 20 μL of 0.15 M NaOH 
for 10 minutes at room temperature to denature DNA strands. Beads 
were placed back on the DynaMag-2 magnetic separator and washed 
one time with 20 μL 0.1 M NaOH, one time with 1 mL 1X W&B, two times 
with 1 mL EB, and resuspended in 8 μL EB + 10 μL 2X Kapa HiFI HotStart 
Ready Mix. Primers and PCR reaction mix were added as above.
In the indicated experiments, i3Neurons were treated with the follow-
ing compounds: Aphidicolin (Aph; 5 μM), etoposide (50 μM), olaparib 
(10 μM), velaparib (10 μM) or tazaparib (1 μM) were added along with 
EdU at 18 hours prior to harvest. POLAi (1 μM) or Aph (50 μM) was 
added with EdU 14 hours or 24 hours prior to harvest, respectively. 
Hydroxyurea (HU; 10 mM) powder was dissolved fresh into water to 
make a 1 M stock each time it was used. HU was added on day 3 of dif-
ferentiation and again on day 6 at 18 hours prior to harvest along with 
EdU for a total of 4 days of treatment. For dideoxynucleoside (ddN) 
chain termination,
5 μM of each of ddA, ddT, ddG, and ddC chain-terminating nucleo-
sides (20 μM total) were added to i3Neuron culture for 18 hours prior 
to cell harvesting for END-seq and S1-END-seq experiments.
END-seq and S1-END-seq
To dissociate i3Neurons for use in END-Seq, we performed a papain 
dissociation protocol modified from a previous protocol46. Papain 
(Worthington Biochemical Cat: LK003178) was dissolved into Try-
pLE™ Express Enzyme (1X) no phenol red and warmed at 37°C for 10 
minutes. Then, day 7 i3Neurons on a 15cm plate were washed with PBS 
and treated with 5mL papain/TRPLE for 1 minute at 37°C. Papain was 
removed with gentle pipetting and 5mL of trituration solution was 
added (30mL i3Neuron Culture Media,10 μM ROCK inhibitor, and 1 vial 
of DNAse freshly dissolved). Cells were collected and gently pipetted 
3-10 times in a conical tube using a wide-bore 10mL pipet, being careful 
not to over-digest the sample. Cells were then washed with PBS, pel-
leted and resuspended in PBS containing 0.1% BSA and 0.5mM EDTA, 
and kept on ice. Cells were processed for END-seq as described47. For 
S1-END-seq, cells were collected and embedded in 1% agarose plugs, 
lysed and digested with Proteinase K (1 hour at 50°C, followed by 7 
hours at 37°C), washed with TE buffer, and then treated with RNAse A 
for 1 hour at 37°C. Plugs were then washed in EB and equilibrated in S1 
nuclease buffer (40 mM sodium acetate pH 4.5, 300 mM NaCl, 2 mM 
ZnSO4) for 30 minutes. 1.8 U of S1 nuclease was added to 100 μL of S1 
nuclease buffer per plug and incubated on ice for 15 minutes to allow for 
the enzyme to diffuse into the plug. The reaction mix was then placed 
at 37°C for 20 minutes before addition of EDTA (10 mM final concentra-
tion) to terminate the reaction. Finally, plugs were processed through 
the standard END-seq protocol.
AsiSI induction in pre-B cells
Abelson-transformed murine pre-B cells48 were retrovirally transduced 
with tetracycline-inducible ER-AsiSI49. Cells were arrested in G1 with 3 
μM imatinib for 24 hours, followed by addition of 3 μg/mL doxycycline 
for 24 hours, and then further addition of 1 μM 4OHT for 18 hours to 
induce AsiSI nuclear localization, as previously described19.
Construction of the Dox-Cas9-D10A nickase
Dox-inducible Cas9-D10A was constructed using isothermal assembly50. 
Briefly, a plasmid encoding Dox-inducible Cas9 nuclease was obtained 
from Addgene. pCW-Cas9-Blast was a gift from Mohan Babu (Addgene 
plasmid # 83481; http://n2t.net/addgene:83481; RRID: Addgene_83481). 
This plasmid was digested with NheI/BamHI and assembled with 2 
PCR fragments (Nickase-P1, Nickase-P2) and transformed into com-
petent cells. Gel extracted PCR fragments of Nickase-P1, Nickase-P2 
were generated using the Q5 HotStart 2X mastermix with the primers 
listed below using Addgene-83481 as template.
MCF10A Cas9D10A inducible cell line
To produce the MCF10A Cas9-D10A inducible cell line, we infected 
MCF10A cells (sourced from ATCC, not aunthenticated, and not myco-
plasma tested) with lentivirus containing Dox-Cas9-D10A and cells 
were selected with 10 μg/mL blasticidin. Cas9-D10A expression was 
induced by 3 μg/mL doxycycline and confirmed by Western Blotting. 
Three guide RNAs (sequences: 5’-TGGGGCGTTTATCCGATGTC-3’; 
5’-GCACTAGCCGGCCCGGACGT-3’; 5’- CCAGCCTGGTAGCGCCCCCA-3’) 
were cloned into Lenti-Guide-NLS–GFP vector51 and the MCF10A 
Cas9-D10A inducible cell line containing the three guide RNAs 
were selected with 2 μg/mL puromycin. For identifying the nicks by 
S1-END-seq, cells were arrested in G1 for 48 hours with 5 μM Palbociclib 
with doxycycline added during the last 24 hours to induce Cas9D10A, 
followed by cell harvesting and S1-END-seq processing.
ChIP-seq and Western blotting
15 million i3Neuron or rat neurons were fixed in 1% formaldehyde at 37°C 
for 10 minutes. The fixation reaction was quenched with glycine at a 
final concentration of 125 mM. Cells were spun down and washed twice 
with chilled PBS, and pellets were then snap frozen on dry ice and finally 
stored at -80°C until sonication. Sonication, immunoprecipitation, 
and library preparation steps were done as previously reported17. All 
antibodies were pre-conjugated to 40 μL of magnetic Protein A beads 
prior to immunoprecipitations: H3K4me1 (5 μg, Abcam #8895); MLL4 
(antibody courtesy of Kai Ge); H3K27ac (5 μg, Abcam #4729); H3K27me3 
(5 μg, Millipore #CS200603); H3K4me3 (6 μL Abcam #8580); H3K9me3 
(10 μg, Active Motif, Cat. No. 39765); CTCF (6 μl, Millipore, Cat. No. 
07-729); RNA Polymerase II (8 μg, Abcam #26721); H3K36me3 (5 μg, 
Abcam Cat. No. ab9050); anti-pan-ADP-ribose (5 μg, Millipore-Sigma 
MABE1016); XRCC1 (2.6 μg, Novus, Cat. No. NBP1-87154). For Western 
blotting, cells were collected and lysed in a buffer containing 50 mM 
Tris-HCl (pH 7.5), 200 mM NaCl, 5% Tween-20, 0.5% NP-40, 2 mM PMSF, 
2.5 mM β-glycerophosphate (all from Sigma-Aldrich) and protease 
inhibitor cocktail tablet (complete Mini, Roche Diagnostics). Equal 
amounts of protein were loaded into precast mini-gels (Invitrogen) 
and resolved by SDS-PAGE. Proteins were blotted onto a nitrocellu-
lose membrane, blocked with Intercept (TBS) blocking buffer (LI-COR 
Biosciences) and incubated with the corresponding primary/second-
ary antibodies: anti-DNA polymerase β (1:1000, Millipore #ABE1408), 
anti-Tubulin (1:10,000, Sigma-Aldrich #T5168), IRDye 800 CW goat 
Fragment Forward Primer Reverse Primer
Nickase-P1 GTCAGATCGCCTGGAGAATTG tgC CAGGCCGATGCTGTACTTCT





























anti-rabbit (1:15,000, Li-Cor #926-32211), and IRDye 680 RD goat 
anti-mouse (1:15,000, Li-Cor #926-68070).
Selective chemical labeling and capture of 5hmC and 5fC
5hmC-Seal was performed as previously described52 with modifications. 
Briefly, 80 μg genomic DNA was resuspended in TE buffer and soni-
cated to 200 bp fragments using a Covaris S220 sonicator. Fragmented 
DNA was precipitated by ethanol and sodium acetate and resuspended 
in TE buffer. The selective 5hmC chemical labeling was performed 
in 100 μl glucosylation buffer (50 mM HEPES buffer pH 8.0, 25 mM 
MgCl2) containing above fragmented DNA, β-GT (NEB, Cat. No. M0357), 
UDP-Azide-Glucose (Active Motif, Cat. No. 55020), and incubated at 
37°C for 1.5 hr. After the reaction, DNA was cleaned up with QIAquick 
Nucleotide Removal Kit. The labeled DNA was eluted with ddH2O, after 
which 1mM DBCO-PEG4-Biotin (Click Chemistry Tools) was added and 
incubated at 37°C for 2 hours. Then, the biotin-labeled DNA was pulled 
down by C1 Streptavidin beads (ThermoFisher, Cat. No. 650-01) for 
30 minutes at room temperature. The captured DNA fragments were 
processed for library construction as described in SAR-seq (above).
For 5fC-SEAL, we modified the previously described protocol10, which 
reduces 5fC to 5hmC using NaBH4
53. We labeled the newly generated 
5hmC (derived from 5fC reduction with NaBH4) with an azide-modified 
glucose as described above for 5hmC-Seal. In brief, 80 μg of fragmented 
i3Neurons genomic DNA was incubated in 100 μl glucosylation buffer 
(50 mM HEPES buffer pH 8.0, 25 mM MgCl2) containing unmodified 
UDP-Glucose (NEB, Cat No. M0357), and β-GT for 1.5 hours at 37°C. The 
labeled DNA was cleaned up with QIAquick Nucleotide Removal Kit. 
Then, an equal volume of freshly prepared NaBH4 (Aldrich, Cat. No. 
213462) solution was added to the glucose-blocked DNA solution. The 
reaction mixture was vortexed and incubated in a Thermomixer for 15 
minutes at room temperature. The chemical labeling and capture were 
performed as described above for 5hmC-SEAL.
In situ Hi-C from hiPSC-derived i3Neurons
Two in situ Hi-C libraries were generated from 10 million cultured 
hiPSC-derived i3Neurons as described in54. Briefly, in situ Hi-C consists 
of 7 steps: (1) crosslinking cells with formaldehyde, (2) DNA digestion 
using MboI, (3) filling in and marking ends with Biotin, (4) proximity 
ligation, (5) DNA shearing, (6) pulling down the biotinylated ligation 
junctions with streptavidin beads, and (7) paired end sequencing. 
As quality control (QC), we confirmed efficient restriction, ligation 
and DNA shearing with an agarose DNA gel and for appropriate size 
selection in using Agilent 4200 TapeStation system after steps (5) and 
(6). For the final QC, we performed 100 paired end sequencing on the 
Illumina Nextseq to assess quality of the libraries based on percent of 
Intra-chromosomal reads, long Range (>20Kb) reads, and Library Com-
plexity. The HiC libraries were sequenced on 150 paired end sequencing 
using Illumina Novaseq 6000.
RNA extraction, RNA-seq and quantitative real-time PCR (RT-PCR)
To extract RNA, cells were plated on 6-well dishes, washed with PBS, and 
then 500 μL of tri-reagent (Zymo research corporation, Cat. No. R2050-
1-200) was added directly to the cells. The lysed cells were collected 
using a cell scraper. To isolate RNA, we used a Direct-zol RNA miniprep 
kit (Zymo Research Corporation, Cat. No. R2052), following manufac-
turer’s instructions including the optional DNAse step. For QT-PCR, 
total RNA was reverse transcribed with iSCRIPT Advanced cDNA Syn-
thesis Kit (Bio-Rad, Cat. No. 1725037) following manufacturer’s instruc-
tions. The resulting cDNA was diluted 10-fold and used for quantitative 
real-time PCR (qRT-PCR) analyses with specific primer and probe sets 
(Bio-Rad, ACTB qHsaCEP0036280; PARP1 qHsaCEP0052423; XRCC1 
qHsaCIP0033686; POLβ qHsaCEP0057881; FEN1 qHsaCEP0039485; 
PNKP qHsaCEP0057803 in a final volume of 20 μL, which contained 
10 μL of SsoAdvanced™ Universal Probes Supermix (Biorad, Cat. No. 
1725280), 3 μL of cDNA. qRT-PCR was performed in triplicate wells per 
sample on a CFX96 Real-Time System (Biorad). For RNA sequencing, 
six biological replicates were sequenced. Total RNA was enriched for 
polyA and sequenced 2x75 bp on a HiSeq machine.
ATAC-seq
ATAC-seq was performed as described previously55. i3Neurons were 
grown on 96-well plates (0.05x106 cells per well). Cells were washed gen-
tly with PBS. Then, 100 μL of accutase per well was added and removed, 
and the plate was incubated at 37°C for 5 minutes. 50 μL cold lysis buffer 
(10 mM Tris-HCl, pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% IGEPAL CA-630) 
was added directly to the well for 10 minutes. Cells were then pipetted 
10-20 times to break clumps and centrifuged at 500 × g for 10 minutes 
at 4°C. The nuclei pellet was resuspended in the Nextera transposition 
reaction mix (25 μL 2x TD Buffer, 2.5 μL Nextera Tn5 transposase (Illu-
mina, Cat. No. FC-121-1030), and 22.5 μL nuclease free H2O) on ice, then 
incubated for 30 minutes at 37°C. The tagmented DNA was purified using 
the Qiagen MinElute kit and eluted with 10 μL Elution Buffer. Following 
purification, library fragments were amplified using the Nextera index kit 
(Illumina, Cat. No. FC-121-1011) under the following cycling conditions: 
72°C for 5 minutes, 98°C for 30 seconds, followed by thermocycling at 
98°C for 10 seconds, 63°C for 30 seconds, and 72°C for 1 minute for a 
total of five cycles. To prevent saturation due to over-amplification, a 
5 μL aliquot was then removed and subjected to qPCR for 20 cycles for 
calculation of the optimal number of cycles needed for the 45 μL reaction 
that remained. The number of additional cycles required was determined 
by plotting linear Rn vs. Cycle and calculating the cycle number corre-
sponding to a quarter of the maximum fluorescence intensity. Adding 
seven cycles to this estimate was found to yield optimal libraries. PCR 
reactions were subsequently cleaned with Agencourt AMPure XP beads 
(Beckman Coulter), run on a 2% agarose gel and a smear of 200-800 bp 
was cut and gel purified using QIAquick Gel Extraction Kit (QIAGEN). 
Library concentration was determined with KAPA Library Quantification 
Kit for Illumina Platforms (Kapa Biosystems). Sequencing was performed 
on the Illumina Nextseq500 (75 bp paired-end reads).
Genome alignment
SAR-seq, END-seq, ChIP-seq and SEAL reads were aligned to the refer-
ence genome (hg19 for human i3Neuron and iMuscle, mm10 for mouse 
pre B cells or rn6 for rat primary neurons) using bowtie (v1.1.2)56 with 
parameters -n 3 -l 50 -k 1 for END-seq and -n 2 -l 50 -m 1 for the rest. 
ATAC-seq reads were aligned by bowtie (v2.4.1)57. RNA-seq reads were 
aligned by STAR (v2.7.6a)58. Functions “view” and “sort” of samtools 
(v1.11)59 were used to convert and sort the aligned sam files to sorted 
bam files. Bam files were further converted to bed files by the bedtools 
(v2.29.2) bamToBed command60. Mitochondrial reads were removed 
in SAR-seq for intensity comparisons.
Peak calling
We used MACS (v1.4.3)61 to call SAR-seq, XRCC1 ChIP-seq and 
ATAC-seq peaks. SAR-seq XRCC1, and CTCF ChIP-seq peaks with >10 
fold-enrichment over background were kept. Peaks of hisone modifi-
cation determined by ChIP-seq peaks were called by SICER62 v2-1.0.2 
with default parameters. Peaks within blacklisted regions (https://sites.
google.com/site/anshulkundaje/projects/blacklists) were filtered63. 
Overlapped SAR-seq peaks from three non-treated replicates shown 
in Figure 1b were used for most of the analyses in this paper. As peaks 
of ddN S1-END-seq are always clustered, subpeaks were called by the 
PeakSplitter tool of PeakAnalyzer with parameters -c 15 -v 0.664. Peak 
summits on both strands were identified, and the distance between 
peaks summit on the negative strand to its closed peak summit on the 
plus strand was calculated and represented in Fig 4d.
Quantification for sequencing data
For SAR-seq, SEAL, and ChIP-seq reads per kilobase of transcript, per 




























per kilobase of transcript per million mapped reads (FPKM) was cal-
culated by cufflinks41 (v2.2.1) based on the annotation from GENCODE 
v3365. Mean values of replicates were used for analyses.
Enhancer enrichment and super enhancer identification
Bedtools shuffle command with parameter (-chrom) was used to 
generate 1,000 random sets for SAR-seq peaks and ATAC-seq peaks, 
respectively, in order to estimate enrichments at genomic features. 
1 kb regions upstream of transcription start sites from GENCODE v33 
annotation were defined as promoters in analyses. Super enhancers 
were separated from conventional enhancers by identifying an inflec-
tion point of H3K27ac signal versus enhancer rank66.
Gene Ontology (GO) analysis
We used the DAVID web-tool67 to find the GO terms enriched for genes 
containing the top 2,000 SAR-seq peaks. The most significant Gene 
Ontology Biological Process terms and their associated FDR values 
were reported.
Motif analysis
MEME-ChIP68 of MEME suite was used to identify the common sequence 
motif of the nucleotide sequences from ±500 bp around the summits 
for the top 5,000 SAR-seq peaks. The composite DNA sequence motif 
shown in Fig 4e was plot by ggseqlogo in R.
Kinetics Model for EdU labeling
The rate of EdU labeling was estimated under the assumptions that the 
fraction of a synthesis event at a given site is fixed with different EdU 
incorporation times and 18 hours is enough for EdU to incorporate all 
synthesis events at a given site. The fraction of EdU labeled synthesis 
event at h hours at a given site was denoted as [EdU]h=1-e
-kh. k represents 
the rate of EdU labeling at a given site and [EdU]h was estimated by 
SAR-seq intensity at h hours divided by SAR-seq intensity at 18 hours. 
The intensity values (RPKM) of SAR-seq at different time points (1, 2, 
4, 8 and 18 hours of EdU) was fitted to the function [EdU]h = 1-e
-kh using 
the nls package in R. The k value shown in Extended Data Fig. 2b was 
derived using the top 2,000 SAR-seq peaks.
Hi-C analysis
Using Juicer software69, .hic files were generated, and normalized con-
tact matrices and observed over expected normalized contact matrices 
were obtained with a dump command. Loop or domain calls were also 
done by juicer software69, and interaction matrices were visualized 
by Juicebox software. After processing two replicates, final map was 
generated by merging these two replicates. The final bin resolution 
of the Hi-C map was 1 kb. From 2.1B raw reads generated by together 
with QC and data-generation runs, we obtained 1.5B final total contacts 
which are over Q30.
For compartment analysis, PC1 eigen vector values are extracted 
in 50k resolution by juicer software, then sign of eigen vector in each 
chromosome was adjusted according to the H3K27ac, H3K4me1 and 
ATAC-seq peaks distribution pattern in whole chromosome. Among 
H3K4me1 peaks which were not overlapped with TSS within 1kb, 
peaks overlapping with SARseq peaks were extracted for the analysis 
(SAR-seq+H3K4me1+). 10,000 random sequence were generated by 
bedtools random program with 2600 nt length which is the average 
length of H3K4me1 peaks. While 40% of random sequences are located 
in A compartment, 63% of SAR-seq +H3K4me1+ peaks were located in 
A compartment.
Visualization
BedGraph files were generated by bedtools genomecov, normalized 
by reads per million (RPM) and then converted to bigWig files using 
bedGraphToBigWig from UCSC pre-compiled utilities for visualization 
at UCSC genome browser70,71.
Data matrices for heatmaps were calculated by computeMatrix and 
plotted by plotHeatmap of deepTools suite72. Venn diagrams were plot-
ted by VennDiagram package in R. Confocal images were processed 
using FIJI. Schematics were created using BioRender, and figures com-
piled in Adobe Illustrator.
Quantification of Confocal Images
Confocal images were quantified using Nikon software. Images were 
first background subtracted. Then nuclei or EdU-positive cells were 
identified and counted using bright spot detection. Corresponding 
PAR signal intensity was measured per cell and reported as a mean. 
Data compilation and statistical analyses were performed using PRISM 
software.
Statistical Analysis
Statistical analysis was performed using R version 3.6.2 (http://
www.r-project.org). The statistical tests are reported in the figure 
legend and main text.
Reporting summary
Further information on research design is available in the Nature 
Research Reporting Summary linked to this paper.
Data availability
The SARseq, S1-ENDseq, ChIPseq, data have been deposited in the Gene 
Expression Omnibus (GEO) database under the accession number 
GSE167259. iPSC enhancers were identified by H3K4me1 ChIP-seq from 
an ENCODE iPSC cell line (GSM2527632). Experimentally-validated 
enhancers was from VISTA genome browser for enhancers: https://
enhancer.lbl.gov/.
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Extended Data Fig. 1 | Discrete genomic loci in neurons are associated with 
ongoing DNA synthesis. a) Schematic of SAR-seq (DNA synthesis associated 
with repair sequencing) methodology. Neurons grown in culture (1) are 
incubated with EdU to label sites of DNA repair synthesis (2). The incorporated 
genomic EdU is then conjugated to biotin via click chemistry (3), sheared by 
sonication to fragments of 150-200 bp and captured with streptavidin beads 
(4). Enriched DNA sequences are then PCR-amplified and subjected to 
next-generation sequencing (5). b) Genome browser screenshot displaying 
SAR-seq profiles as normalized read density (reads per million, RPM) for human 
iPSC-derived neurons (i3Neurons). Three independent biological replicates are 
shown as well as input. Neurons were labeled with EdU for 18 hours and 
harvested on day 7 after induction of neuronal differentiation. All coordinates 
provided are from the hg19 reference genome for i3Neurons. c) Venn diagram 
showing the overlap of SAR-seq peaks in i3Neurons for three independent 
biological replicates. d) Scatter plots showing correlations of SAR-seq 
intensities (SAR-seq reads per kilobase per million mapped reads, RPKM) 
between three replicates in i3Neurons. Pearson correlation coefficients and p 
values are indicated. e) Left panel: Representative images of EdU-biotin 
staining (green) showing cell proliferation in iPSCs, but not in post-mitotic 
i3Neurons. i3Neurons were treated with EdU on day 3 or day 6 and fixed on day 7. 
iPSCs were treated with EdU for 24h and fixed. Cells were counterstained with 
DAPI (blue). Note that different imaging conditions were used for iPSCs and 
i3Neurons in the representative images. Right panel: quantification of EdU 
positive cells. Each dot represents the percent of dividing cells in one image 
(ipsc: n=8 images, n=397/410 cells EdU-positive; iNeuron day 3: n=8 images, 
n=35/483 cells EdU-positive; iNeuron day 7: n=8 images, n=0/523 cells 




























Extended Data Fig. 2 | Genomic characteristics of SAR-seq peaks. a) 
Genome browser screenshot showing SAR-seq in i3Neurons treated with 
hydroxyurea (HU, n=1) or polymerase alpha inhibitor (POLαi, n=2). NT: 
non-treated. b) Scatter plots showing SAR-seq intensities (RPKM) for HU- (left) 
and POLαi- (right) treated compared to non-treated (NT) samples. c) Flow 
cytometry cell cycle profile of pre-B cells treated or non-treated (NT) with 
POLαi. Cells were pulsed with EdU for 30 minutes before collecting cells for 
flow cytometry. Cells were counterstained with DAPI (n=1). For an example of 
gating strategy used for flow cytometry in c and Extended Data 9b, please see 
Supplementary Figure 1. d) Histogram of individual SAR-seq peak widths, 
revealing an average peak width of 901 bp. e) Genome browser screenshot 
showing SAR-seq in i3Neurons harvested after 1 hour, 2 hours, 4 hours, 8 hours, 
or 18 hours of EdU incubation (n=2 for each). f) Graph showing the fraction of 
EdU labeling in i3Neurons (relative to maximum labeling at 18 hours) as a 
function of time calculated from top 2000 peaks. Red points and error bars 
represent mean and standard deviation of the relative levels of EdU measured 
from experimental data. Black line represents the theoretical model after 




























Extended Data Fig. 3 | SAR-seq enrichment at neuronal intragenic regions. 
a) Genome browser screenshot of chromosome 7 showing lack of localized 
DNA synthesis in two independent biological replicates of SAR-seq performed 
in iMuscle cells (n=2) incubated with EdU for 18 hours compared to SAR-seq in 
i3Neurons as well as input DNA. b) Genome browser screenshot displaying 
SAR-seq peak at a representative AsiS1 restriction enzyme site (tick mark). 
AsiS1 expression was induced for 18 hours (+Dox, n=1) vs non-treated (-Dox, 
n=1) in G0-arrested, Abelson virus-transformed murine pre-B cells as 
described19. c) Distribution of SAR-seq peaks with respect to different genomic 
features compared to genome-wide distribution of the hg19 human reference 
genome. Promoters are defined as 1kb upstream of transcription start sites. 
Distal intergenic represents promoter-excluded intergenic regions. d) Fold 
enrichment of SAR-seq peaks in intergenic regions, intragenic regions and 
expressed genes compared to 1000 sets of randomly shuffled regions of the 
same sizes and chromosome distribution (one-sided Fisher’s Exact test, ****p 
<2.2e-16, NS: not significant). e) Left panel: Scatterplot showing correlation of 
SAR-seq intensity (RPKM) with transcript level of genes containing SAR-seq 
peaks measured by RNA-seq (n=3) (Fragments Per Kilobase of transcript per 
Million mapped reads, FPKM) in i3Neurons. 71% of SAR-seq peaks are at 
expressed genes (FPKM≥0.1; red dashed line: FPKM=0.1). Right panel: 
correlation of SAR-seq intensity with transcript levels of linked genes 
determined by pcHiC in i3Neurons (red dashed line: FPKM=0.1). Spearman 
correlation coefficients and p values are indicated. f) Genome browser 
screenshot comparing SAR-seq vs. strand-specific SAR-seq (n=3) that 
discriminates which strand is labeled with EdU in i3Neurons. Both strands show 
labeling in three biological replicates. Strand-specific SAR-seq reads are 



























Extended Data Fig. 4 | Motif discovery of SAR peaks and comparison with 
ATAC-seq peaks. a) Motif analysis for sequences within ± 500 bp surrounding 
the summit of the top 5,000 SAR-seq peaks in i3Neurons. Upper panel: the best 
motif discovered by the MEME suite. 1,384 out of 5,000 sites have this 
motif. Middle panel: TOMTOM motif tool used to compare SAR-seq motif 
shown above with databases of known motifs. The transcription factor 
ONECUT1 was identified as the most similar motif and its consensus sequence 
is shown. P value for motif comparison with ONECUT1 motif is 
indicated. Bottom panel: position distribution of the best motif (upper panel) 
within ± 500 bp of the SAR-seq peak summit. The best motif is centered on the 
SAR-seq peak summit. b) Venn diagram illustrating the overlap between 
H3K4me1 ChIP-seq, ATAC-seq and SAR-seq peaks in i3Neurons. Statistical 
significance of the overlaps between SAR-seq, H3K4me1 ChIP-seq and 
ATAC-seq peaks was determined using randomly shuffled datasets (N=1,000) 
by one-sided Fisher’s Exact test (the p value for overlap between H3K4me1 
ChIP-seq/SAR-seq peaks is p<2.2e-16, and for ATAC-seq/SAR-seq peaks is  
p <2.2e-16). Fraction of different overlapping groups are labeled in red for 
SAR-seq peaks, green for ATAC-seq peaks and blue for H3K4me1 ChIP-seq 
peaks. c) Heatmaps of SAR-seq and ATAC-seq signal ±1kb around SAR-seq peak 
summits in i3Neurons, ordered by SAR-seq intensity. d) Scatter plot comparing 
widths of ATAC-seq peaks and SAR-seq peaks for top 10000 overlapped peaks 
in i3Neurons. Pearson correlation coefficient and p value are indicated. e) 
Distribution of SAR-seq and ATAC-seq peaks with respect to different genomic 
features compared to genome-wide distribution on the hg19 human reference 
genome. Promoters are defined as 1 kb upstream of transcription start sites 
and distal intergenic represents promoter-excluded intergenic regions. f) Bar 
graph showing the fold enrichment of SAR-seq and ATAC-seq peaks located at 
enhancers (black) and promoters (grey) compared to 1000 sets of randomly 
shuffled regions of the same sizes and chromosome distributions, respectively 
(one-sided Fisher’s Exact test, ****p <2.2e-16, NS: p=0.0783, not significant). g) 
Heatmap of RNA Polymerase II (Pol II, n=1) ChIP-seq and SAR-seq in i3Neurons 





























Extended Data Fig. 5 | The correlation between SAR-seq and chromatin 
features. a) Heatmaps of SAR-seq and ChIP-seqs of enhancer markers 
(H3K4me1, H3K27ac and MLL4), other chromatin markers at accessible regions 
(H3K4me3, H3K36me3 and CTCF) and chromatin silencing markers 
(H3K27me3 and H3K9me3) ±1kb around the SAR-seq peak summit in i3Neurons, 
ordered by SAR-seq intensity. b) Scatter plots showing the correlation between 
SAR-seq intensity and ATAC-seq, H3K4me1, H3K27ac and MLL4 ChIP-seq 
intensities (RPKM) ±1 kb around the SAR-seq peak summits in i3Neurons. 
Spearman correlation coefficients and p values are indicated. c) Fold 
enrichment of SAR-seq peaks at ATAC-seq peaks, ChIP-seq peaks of enhancer 
related marks (H3K4me1, H3K27ac and MLL4), additional chromatin marks at 
accessible regions (H3K4me3, H3K36me3 and CTCF) (all n=1) and chromatin 
silencing marks (H3K27me3 and H3K9me3) (both n=1) in i3Neurons. N=1,000 
randomly shuffled datasets were generated to test the significance using 
one-sided Fisher’s Exact test (p<2.2e-16 for H3K4me1, H3K27ac, ATAC-seq and 
MLL4, p=1.85e-316 for H3K4me3, p=0.00116 for CTCF, **p<0.001, ****p 
<0.00001, NS: not significant). d) Heatmaps of SAR-seq and H3K4me1 ChIP-seq 
signal ±1kb around the SAR-seq peak summit in primary rat cortical neurons, 
ordered by SAR-seq intensity. e) Venn diagram showing the overlap between 
H3K4me1 and SAR-seq peaks in rat primary neurons. N=1,000 randomly 
shuffled datasets were generated to test the significance using one-sided 
Fisher’s Exact test: p <2.2e-16. f) Scatter plot showing the correlation between 
SAR-seq and H3K4me1 ChIP-seq intensities (RPKM) ±1kb around the SAR-seq 




























Extended Data Fig. 6 | SAR-seq enrichment at neuronal enhancers.  
a) Boxplot showing Hi-C contacts (left, n=4) and H3K27ac (right, n=1) levels at 
enhancers with SAR-seq peaks (red) or without SAR-seq peaks (grey). Contacts 
were defined as Hi-C interactions between an H3K27ac+ enhancer (with and 
without SAR) and its closest promoter within the TAD domain. For comparative 
purposes observed contacts were normalized to expected contacts. The top, 
centre mark, and bottom hinges of the box plots, respectively, indicate the 
75th, median, and 25th percentile values. Statistical significance was 
determined using one sided Wilcoxon rank sum test. P is 1.64e-225 for HiC 
contacts and p<2.2e-16 for H3K27ac intensity (****p <0.00001). b) Fold 
enrichment of SAR-seq peaks at in vivo validated enhancers from VISTA 
Enhancer Browser database that overlap with H3K4me1 ChIP-seq peaks (left, 
p=1.42e-53) or at promoter interacting regions determined by pcHiC (right, 
p=1.574e-09). N=1,000 randomly shuffled datasets were generated to test the 
significance using one-sided Fisher’s Exact test (**p<0.001, ****p <0.00001).  
c) Genome browser screenshots showing SAR-seq, H3K4me1 and H3K27ac 
ChIP-seq, and pcHiC and Hi-C profiles at representative enhancers (highlighted 
in orange) interacting with CDK5RAP3 promoter and (d) the DRD2 promoter. 
Both enhancers have been validated to promote transcription of their 
respective genes using CRIPSR techniques in i3Neurons10. The CDK5RAP3 
enhancer also overlaps with in vivo validated enhancers from VISTA Enhancer 
Browser database. In the Hi-C contact matrix the intensity of each pixel 
represents the normalized number of contacts between a pair of loci. The 
maximum intensity is indicated at the lower left corner. e) Pie-chart showing 
distribution of i3Neuron SAR-seq peaks in iPSC-specific, i3Neuron- specific and 
shared iPSC- and i3Neuron-enhancers. Approximately 56 million and 49 million 
single end reads were sequenced for the H3K4me1 ChIP-seq in iPSC and 
i3Neurons, respectively, with approximately 100,000 peaks called in both cell 
types. f) Top biological processes enriched for the genes containing the 2,000 
most intense SAR-seq peaks determined by Gene Ontology (GO) analysis. The 
x-axis represents the enrichment value as the logarithm of False Discovery 
Rates (FDR). g) H3K27ac signal at enhancers in i3Neurons ranked by H3K27ac 
ChIP-seq intensity. Red dashed line indicates the inflection point of H3K27ac 
signal used to determine super enhancers (cutoff: 1000). Accordingly, 1,385 
enhancers were defined as super enhancers. h) Bar graph showing the fraction 
of super-enhancers (left) and conventional enhancers (right) that overlap with 
SAR-seq peaks. The super-enhancers in the i3Neurons were defined by H3K27ac 




























Extended Data Fig. 7 | PARP and XRCC1 recruited to DNA repair sites.  
a) Quantification of PAR levels with (n=422 cells) and without (n=541 cells)  
MMS treatment (red line: mean value). Each dot represents one cell.  
Statistical significance was determined using two sided Mann-Whitney test  
(**** p<0.0001). Data are representative of three independent experiments.  
b) Anti-ADP-ribose ChIP-seq signal (n=1) at an AsiSI restriction enzyme cut site 
(tick mark) in Abelson virus-transformed murine pre-B cells. Cells were 
arrested in G0, and AsiSI double-strand breaks were induced for 18 hours prior 
to ChIP. Note that ADP-ribose is enriched at cleaved AsiSI sites and is increased 
by 20 min treatment with PARGi prior to fixation (AsiSI + PARGi), which is 
indicative of the presence of poly(ADP-ribose). c) Genome browser screenshot 
illustrating the overlap between SAR-seq (n=3), PAR (n=1) and XRCC1 (n=1) 
ChIP-seq signals in i3Neurons. Cells for PAR ChIP-seq were incubated with 



























Extended Data Fig. 8 | Mapping regions of DNA damage and repair in 
neurons. a) Genome browser example of SAR-seq profiles in non-treated (NT) 
or etoposide (ETO)-treated (18 hours, 50μM) i3Neurons. Data are from two 
biological replicates. b) Heatmaps for SAR-seq in nontreated (NT) or 
etoposide- (ETO) treated (18 hours 50μM) i3Neurons at -2kb to +5kb of the 
transcription start sites (TSS) ordered by ETO SAR-seq intensity. c) 
Immunofluorescence staining of DSB markers γ-H2AX (red) and 53BP1 (green) 
in non-treated or one-hour ETO treated i3Neurons. Data are representative of 
three independent experiments. d) Genome browser showing SAR-seq and 
END-seq profiles in non-treated i3Neurons. Note that END-seq, which detects 
DSBs specifically19, does not detect any enriched signal (i.e. above background) 
at SAR-seq peaks. END-seq signals are separated by positive (black) and 
negative (grey) strands. END-seq data are representative of two independent 
experiments. e) Heatmaps of SAR-seq and XRCC1 ChIP-seq (n=1) ±1kb around 
SAR-seq peak summits in cultured rat primary neurons, ordered by SAR-seq 
intensity. f) Scatter plots showing the correlation between SAR-seq and XRCC1 
ChIP-seq intensities (RPKM) ±1kb around the SAR-seq peak summits in 
i3Neuron or rat primary neurons (g), respectively. Spearman correlation 




























Extended Data Fig. 9 | S1-END-seq mapping of SSBs. a) Genome browser 
screenshot showing profiles of SAR-seq and S1-END-seq. Agarose plugs were 
incubated with or without the restriction enzyme Nt.BspQI prior to S1 
treatment (n=1). Zoomed-in view of Nt.BspQI sites (tick mark) display 
S1-END-seq detection upon Nt.BspQI treatment. S1-END-seq reads are 
separated by positive (black) and negative (grey) strands. b) Flow cytometry 
profile of G1-arrested MCF10A cells pulsed with EdU. For G1 arrest, MCF10A 
cells were treated with Palbociclib (1μM) for 48 hours to arrest cells in G1. 
Doxycycline was added in the last 24 hours to induce nickase expression. Data 
representative of three independent experiments. For example of gating 
strategy used for flow cytometry in b and Extended Data 2c, please see 
Supplementary Figure 1. c) Genome browser screenshot showing S1-END-seq 
profiles at three Cas9 nickase targeting sites (tick marks: sgRNAs 1-3) in the 
G1-arrested MCF10A cells treated with doxycycline (+Dox) to induce Cas9 
expression (n=1). S1-END-seq signals are separated by positive (black) and 
negative (grey) strands. d) Heatmaps of SAR-seq and S1-END-seq signal in 
i3Neurons with ddN or without incubation (NT) ±1 kb surrounding the SAR-seq 
peak summits, ordered by SAR-seq intensity. e) Venn diagram showing the 
overlap between S1-END-seq peaks incubated with ddN and SAR-seq peaks in 
i3Neurons. N=1,000 randomly shuffled datasets were generated to test the 
significance using one-sided Fisher’s Exact test: p <2.2e-16. f) Distribution of 
the size of the gaps between positive- and negative-strand S1-END-seq peak 
summits in i3Neurons incubated with ddN. The median gap size is 25 bp (red 
dashed line). Positive-strand peak represents the right end and negative-strand 
peak represents the left end of a detected DSB. g) Aggregate plots showing the 
distribution of CG dinucleotides (black) at ±1kb surrounding SAR-seq peak 
summits overlaid with SAR-seq signal (red). h) Aggregate plots showing the 
distribution of CG dinucleotides (black) at ±1kb around SAR-seq peak summits 




























Extended Data Fig. 10 | PARP, XRCC1 or POLB deficiency increases SAR.  
a) Quantitative RT-PCR analysis showing PARP1 mRNA transcript level in 
i3Neurons after CRISPRi knockdown (sgControl: control non-targeting sgRNA; 
sgPARP1: an sgRNA targeting PARP1), cultured in parallel with samples used for 
SAR-seq. p is 7.72e-07 by unpaired two-tailed Student’s t test, ****: p <0.00001. 
(n=3). b) Genome browser screenshot displaying SAR-seq profiles from two 
biological replicates of i3Neurons treated with PARP inhibitors olaparib, 
talazoparib, veliparib, or CRISPRi-mediated knockdown with a control 
non-targeting sgRNA (sgControl) or an sgRNA targeting PARP1 (sgPARP1), in 
duplicates. NT: non-treated. c) Quantitative RT-PCR analysis showing XRCC1 
mRNA transcript level in i3Neurons after CRISPRi knockdown (sgControl: 
control non-targeting sgRNA; sgXRCC1: an sgRNA targeting XRCC1), cultured 
in parallel with samples used for SAR-seq. p is 1.88e-05 by unpaired two-tailed 
Student’s t test, ****: p <0.00001. (n=3). d) Genome browser screenshots of 
SAR-seq profiles in i3Neurons expressing CRISPRi non-targeting sgRNAs 
(sgControl) or targeting XRCC1 (sgXRCC1), in duplicate. e) Venn diagram 
showing the overlap of SAR-seq peaks between i3Neurons expressing 
non-targeting sgRNA (sgControl) or targeting XRCC1 (sgXRCC1). N=1,000 
random datasets were generated to test significance of overlap (one-sided 
Fisher’s Exact test: p<2.2e-16). f) Quantitative RT-PCR analysis showing POLβ 
mRNA transcript levels in i3Neurons after CRISPRi knockdown (sgControl: 
control non-targeting sgRNA; POLB sg1 or sg2: two independent sgRNAs 
targeting POLβ), cultured in parallel with samples used for SAR-seq.p is 6.98e-05 
for sg1 and 5.82e-05 for sg2 by unpaired two-tailed Student’s t test, ****:  
p <0.00001. (n=3). g) Western blot showing POLB protein levels in i3Neurons 
after CRISPRi knockdown (sgControl: control non-targeting sgRNA; POLB sg1 
or sg2: two independent sgRNAs targeting POLB), cultured in parallel with 
samples used for SAR-seq (n=1). For gel source data, see Supplementary Fig. 2. 
h) Genome browser screenshots of SAR-seq profiles from two biological 
replicates of i3Neurons expressing CRISPRi non-targeting sgRNAs (sgControl) 
or targeting POLβ (sgPOLB), in duplicates. i) Genome browser screenshots of 
SAR-seq profiles from two biological replicates of i3Neurons expressing 
CRISPRi non-targeting sgRNAs (sgControl) or targeting POLβ (sgPOLβ). Cells 
were pre-treated or non-treated (NT) with 50 μM Aph for 24 hours, and then 




























Extended Data Fig. 11 | Localized SSB repair in neurons correlates with sites 
of oxidized 5-methylcytosine. a) Genome browser screenshot of 
chromosome 7 showing SAR-seq profiles from two biological replicates and 
input DNA in i3Neurons without MMS treatment (NT, n=2) or after treatment 
with 0.1mg/ml MMS (n=2) for the final 15 min of an 18 hr incubation with EdU. 
After Streptavidin pull-down and PCR amplification, total DNA was quantified: 
NT rep1: 0.95 μg; NT rep2: 1.7 μg; MMS rep1: 3.8 μg; MMS rep2: 4.5 μg. 
Stochastic DNA damage results in loss of DNA synthesis at recurrent sites. b) 
Quantitative RT-PCR analysis showing PNKP mRNA transcript level in i3Neurons 
after CRISPRi knockdown (sgControl: control non-targeting sgRNA; sg PNKP: 
an sgRNAs targeting PNKP), cultured in parallel with samples used for SAR-seq. 
p is 0.00015 by unpaired two-tailed Student’s t test, ***: p <0.0001. (n=3). c) 
Heatmaps of SAR-seq intensities ±1kb surrounding SAR-seq peak summits for 
i3Neurons expressing non-targeting sgRNA (sgControl, n=2) or sgRNA 
targeting PNKP (sgPNKP, n=2). Aggregate plots of SAR-seq intensity are shown 
in the top panel. d) Heatmap of SAR-seq ±1kb surrounding the transcription 
start site (TSS) in i3Neurons, ordered by SAR-seq intensity. i3Neurons 
expressing CRISPRi non-targeting sgRNAs (sgControl) or targeting PNKP 
(sgPNKP) were either non-treated (NT, n=2) or treated with 25 μM 
camptothecin (CPT, n=2) during incubation with EdU. Aggregate plots of 
SAR-seq intensity are shown in the top panel. e) Scatter plots showing 
correlations of intensities (RPKM) between SSBs (ddN S1-END-seq) and 5fC or 
5hmC, respectively at ±1kb surrounding SAR-seq peak summits for i3Neurons. 
Spearman correlation coefficients and p values are indicated. f) Scatter plots 
showing correlations of intensities (RPKM) between SAR-seq expressing 
sgPOLβ and ddN S1-END-seq, 5fC, or 5hmC at ±1kb surrounding SAR-seq peak 
summits for i3Neurons. Spearman correlation coefficients and p values are 
indicated.
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